Research Article
Gastrointestinal Hemorrhage in Warfarin Anticoagulated Patients: Incidence, Risk Factor, Management, and Outcome
Table 5
Univariate analysis of risk factors of gastrointestinal bleeding in patients taking warfarin.
| Variable | Relative risk | 95% confidence interval | value |
| Age > 65 yrs | 2.5 | 1.3–5.3 | 0.02 | Mean INR* > 2.1 | 2.4 | 1.2–4.5 | 0.01 | History of GIB | 4.6 | 1.8–11.9 | 0.002 | Cirrhosis | 8.9 | 2.7–29.9 | <0.001 | Gender | 0.6 | 0.3–1.2 | 0.2 | Smoking | 1.0 | 0.5–2.3 | 0.8 | Alcohol | 0.7 | 0.3–61.8 | 0.5 | Hypertension | 0.6 | 0.8–3.3 | 0.1 | Cardiovascular disease | 1.5 | 0.7–3.1 | 0.2 | Pulmonary disease | 1.3 | 0.5–3.2 | 0.5 | Renal insufficiency | 1.1 | 0.4–3.2 | 0.8 | Malignancy | 1.2 | 0.5–3.0 | 0.3 | Septic shock | 3.0 | 0.9–10.1 | 0.08 | NSAID | 3.0 | 0.7–12.7 | 0.1 | Aspirin | 0.9 | 0.3–2.7 | 1.0 | Clopidogrel | 0.5 | 0.07–3.9 | 0.5 | Dipyridamole | 2.4 | 0.9–6.2 | 0.08 | Steroids | 1.6 | 0.5–4.6 | 0.4 |
|
|
INR: international normalization ratio. GIB: gastrointestinal bleeding. NSAID: nonsteroidal anti-inflammatory drug.
|